Intra-Cellular Therapies
ITCI
#1799
Rank
HK$71.08 B
Marketcap
HK$670.54
Share price
-0.31%
Change (1 day)
55.82%
Change (1 year)

Intra-Cellular Therapies (ITCI) - P/B ratio

P/B ratio as of November 2024 : 8.01

According to Intra-Cellular Therapies's latest financial reports the company has a price-to-book ratio of 16.2638.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Intra-Cellular Therapies - P/B ratio (from 2013 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3111.752.56%
2022-12-317.64-25.13%
2021-12-3110.2161.93%
2020-12-313.90-60.11%
2019-12-319.77396.25%
2018-12-311.9713.16%
2017-12-311.740.01%
2016-12-311.74-64.33%
2015-12-314.8712.86%
2014-12-314.32-69.19%
2013-12-3114.0

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
1.43-82.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-35.3-541.21%๐Ÿ‡บ๐Ÿ‡ธ USA
2.68-66.59%๐Ÿ‡บ๐Ÿ‡ธ USA